Updated questions and answers on the Windsor Framework

News Category: Regulatory news

Date: 19/06/2024

We have published an updated Q&A document relating to the impact of the Windsor Framework on the regulation of human medicines.

The document is based on questions the HPRA has received from companies and includes updated information on:

  • Joint labels between IE/UK
  • Medicines moving from Northern Ireland to the Republic of Ireland
  • The expiry of Brexit Derogations approved in Ireland

Further questions on this topic can be sent to brexit@hpra.ie. We will continue to update the document as necessary.

See the Brexit section of our website for further updates.

« Back